ConductScience.org, home

Paper495343

Anomalous biological effects of salicylates and prostaglandins.

Glenn EM and 2 others. Agents Actions, 1979. Cited by 14 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Anomalous biological effects of salicylates and prostaglandins. Papers, record 495343. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/495343

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anomalous biological effects of salicylates and prostaglandins.
PubMed
Journal
Agents Actions
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.8
iCite
Revised in PubMed
2019-08-23
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Glenn EME M
2Bowman BJB J
3Rohloff NAN A

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ProstaglandinsMajor topic
SalicylatesMajor topic
Analgesics
Animals
Blood Platelets
Body Temperature
Carrageenan
Edema
In Vitro Techniques
Inflammation
Male
Prostaglandins E
Rats
Stomach Ulcer

Source PubMed

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1823,804Anti-inflammatory drugs, prostaglandins and leucocyte migration.Agents Actions1976https://conductscience.org/library/papers/823804PubMed
24,208,101Drugs which inhibit prostaglandin biosynthesis.Pharmacol Rev1974https://conductscience.org/library/papers/4208101PubMed
3995,953Inhibition of in vitro neutrophil chemotaxis and spontaneous motility by anti-inflammatory agents.Proc Soc Exp Biol Med1976https://conductscience.org/library/papers/995953PubMed
4352,793Recent developments about non-steroidal anti-inflammatory drugs and their mode of action.Gen Pharmacol1978https://conductscience.org/library/papers/352793PubMed
5579,141Antagonism of non-steroidal anti-inflammatory drugs and narcotic analgesics against ethacrynic acid induced writhing.Arzneimittelforschung1977https://conductscience.org/library/papers/579141PubMed
698,976Aspirin and prostaglandins: some recent developments.Agents Actions1978https://conductscience.org/library/papers/98976PubMed
75,698,627Effect of prostaglandin E1 on gastric secretion and ulcer formation in the rat.Gastroenterology1968https://conductscience.org/library/papers/5698627PubMed
8414,527Anti-inflammatory and PG inhibitory effects of phenacetin and acetaminophen.Agents Actions1977https://conductscience.org/library/papers/414527PubMed
94,861,386Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis.Br Med J1967https://conductscience.org/library/papers/4861386PubMed
10174,967Gastric antisecretory and antiulcer properties of PGE2, 15-methyl PGE2, and 16, 16-dimethyl PGE2. Intravenous, oral and intrajejunal administration.Gastroenterology1976https://conductscience.org/library/papers/174967PubMed
11823,876Prostaglandin synthetase activity from human rheumatoid synovial microsomes. Effect of 'aspirin-like' drug therapy.Ann Rheum Dis1976https://conductscience.org/library/papers/823876PubMed
12786,742Prostaglandins as determinants of vascular reactivity.Fed Proc1976https://conductscience.org/library/papers/786742PubMed
1398,977The mode of action of aspirin-like drugs.Agents Actions1978https://conductscience.org/library/papers/98977PubMed
14930,758The effect of drugs in established rabbit monoarticular arthritis.Agents Actions1977https://conductscience.org/library/papers/930758PubMed
15343,556Interaction between anti-inflammatory drugs and inflammatory mediators. A reference to products of arachidonic acid metabolism.Agents Actions Suppl1977https://conductscience.org/library/papers/343556PubMed
165,284,360Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.Nat New Biol1971https://conductscience.org/library/papers/5284360PubMed
174,112,694Characterization of antibody to prostaglandin F 2a .Biochem Biophys Res Commun1972https://conductscience.org/library/papers/4112694PubMed
18602,876Urea compounds that increase the biosynthesis of prostaglandins in vivo--in vitro.Agents Actions1977https://conductscience.org/library/papers/602876PubMed

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
29,743,984Ingredients from Litsea garrettii as Potential Preventive Agents against Oxidative Insult and Inflammatory Response.Oxid Med Cell Longev2018https://conductscience.org/library/papers/29743984PubMed
8,285,140Is aspirin a prodrug for antioxidant and cytokine-modulating oxymetabolites?Agents Actions1993https://conductscience.org/library/papers/8285140PubMed
7,211,578Bio-distribution in rats of some salicylates with low gastric ulcerogenicity.Agents Actions1980https://conductscience.org/library/papers/7211578PubMed
3,390,662Effects of non-steroidal anti-inflammatory drugs on rat gastric mucosal leukotriene C4 and prostanoid release: relation to ethanol-induced injury.Br J Pharmacol1988https://conductscience.org/library/papers/3390662PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/495343

GET https://conductscience.org/api/papers/v1/495343/authors